SCHEMBL13645650

SCHEMBL13645650

C[Si](C)(C)CCc1ccccc1NC(=O)c1ccccc1C(F)(F)F

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.56
HTT P42858 1/20 0.51
RXFP1 Q9HBX9 3/20 0.49
POLB P06746 2/20 0.48
EPHB3 P54753 1/20 0.48
GAA P10253 3/20 0.48
LMNA P02545 1/20 0.48
ALDH1A1 P00352 1/20 0.47
ALOX12 P18054 1/20 0.47
PTGES O14684 1/20 0.47
GRM5 P41594 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
F2R P25116 1/20 0.46
TP53 P04637 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylamine SCHEMBL27566541 0.84 SMN1; SMN2 (0.52) SMN1; SMN2RXFP1POLBGAALMNA
SCHEMBL4671630 0.84 SMN1; SMN2 (0.54) SMN1; SMN2RXFP1POLBEPHB3GAA
SCHEMBL14280281 0.84 SMN1; SMN2 (0.54) SMN1; SMN2RXFP1POLBGAALMNA
SCHEMBL10943427 0.82 SMN1; SMN2 (0.53) SMN1; SMN2HTTRXFP1POLBEPHB3
SCHEMBL12893297 0.82 SMN1; SMN2 (0.53) SMN1; SMN2RXFP1POLBGAALMNA
SCHEMBL13645618 0.82 KMT2A (0.49) RXFP1MEN1KMT2A
SCHEMBL10942213 0.81 SMN1; SMN2 (0.52) SMN1; SMN2RXFP1POLBEPHB3GAA
SCHEMBL14280279 0.81 SLC16A3 (0.55) SMN1; SMN2RXFP1GAALMNAF2R
SCHEMBL12798767 0.81 SMN1; SMN2 (0.46) SMN1; SMN2HTTRXFP1POLBGAA
SCHEMBL3863550 0.81 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598389-B2 Silylated carboxamides BAYER CROPSCIENCE AG (DE) 2009-10-06 US disclosed
US-20070191454-A1 Silylated carboxamides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191454-A1 Silylated carboxamides MRPL21, MRPS22, MRPS34 SMN1; SMN2 2141/4885HTT 4455/4885RXFP1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.